Avid Bioservices Inc (CDMO)

[entdoc]

sindoe, very cool question re. a very cool technology. The surface biomarker in this particular article you are referencing [which is very interesting: thank you!]is an integrin which binds to a commercial product, Integrisense 750. PPHM does have patents applicable to the near infra-red visibility imaging field for better mapping and visualization of cancers pre-op and intra-operatively. Obviously, instead of integrin Bavi binds to "flipped" cell surface phosphatidylserine )-PS). You can see all the cross-referencing of new patents in this field with Bavituximab in this field by simply googling "bavituximab and near infrared luminescence". Thanks for the "heads up".